Blinklab Fpo has released a press release.
BlinkLab Surpasses Key Milestone in Pivotal U.S. Trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Blinklab
- Pause in Trading
- US Autism Diagnostic Study Commences with First Child Tested
- North Shore Pediatric Therapy in Chicago joins Study
- Positive Outcome from FDA Pre-Submission Meeting
- Amended BB1 to Participate in Monash Uni Autism/ADHD MAGNET
Later from Blinklab
- Successful Placement of A$7.66M to Underpin Growth Strategy
- Response to ASX Price and Volume Query
- US Ethics Approval Received for the Main Phase of FDA510(k)
- 2025 Annual Report & Appendix 4E
- Pilot Study Confirms High Diagnostic Accuracy & Readiness
Follow Blinklab into a list and get an email when it puts out news.
Follow Blinklab